Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice.
about
Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancerNovel pancreatic cancer cell lines derived from genetically engineered mouse models of spontaneous pancreatic adenocarcinoma: applications in diagnosis and therapyAnticancer Effect of Ginger Extract against Pancreatic Cancer Cells Mainly through Reactive Oxygen Species-Mediated Autotic Cell DeathDynamic mast cell-stromal cell interactions promote growth of pancreatic cancer.Induction of protective and therapeutic anti-pancreatic cancer immunity using a reconstructed MUC1 DNA vaccine.Calorie restriction decreases murine and human pancreatic tumor cell growth, nuclear factor-κB activation, and inflammation-related gene expression in an insulin-like growth factor-1-dependent manner.32-Phosphorus selectively delivered by listeria to pancreatic cancer demonstrates a strong therapeutic effect.Cancer causes increased mortality and is associated with altered apoptosis in murine sepsis.Tumor Penetrating Theranostic Nanoparticles for Enhancement of Targeted and Image-guided Drug Delivery into Peritoneal Tumors following Intraperitoneal Delivery.Modified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model.The antitumor and immunoadjuvant effects of IFN-alpha in combination with recombinant poxvirus vaccines.In vivo imaging of pancreatic tumours and liver metastases using 7 Tesla MRI in a murine orthotopic pancreatic cancer model and a liver metastases modelStudies on mechanisms of interferon-gamma action in pancreatic cancer using a data-driven and model-based approach.Development and antitumor activity of a BCL-2 targeted single-stranded DNA oligonucleotide.Cholecystokinin mediates progression and metastasis of pancreatic cancer associated with dietary fat.Establishment of an orthotopic pancreatic cancer mouse model: cells suspended and injected in Matrigel.Bacteriolytic therapy of experimental pancreatic carcinoma.Murine pancreatic adenocarcinoma dampens SHIP-1 expression and alters MDSC homeostasis and functionAdiponectin promotes pancreatic cancer progression by inhibiting apoptosis via the activation of AMPK/Sirt1/PGC-1α signaling.Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway.RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD8(+) T cells.Lumican reduces tumor growth via induction of fas-mediated endothelial cell apoptosis.PD-1/PD-L1 blockade together with vaccine therapy facilitates effector T-cell infiltration into pancreatic tumors.Identification of tumorigenic and therapeutically actionable mutations in transplantable mouse tumor cells by exome sequencing.Development of an orthotopic model of invasive pancreatic cancer in an immunocompetent murine host.Tumor necrosis factor induces tumor promoting and anti-tumoral effects on pancreatic cancer via TNFR1.The novel sigma-2 receptor ligand SW43 stabilizes pancreas cancer progression in combination with gemcitabine.Murine pancreatic adenocarcinoma reduces Ikaros expression and disrupts T cell homeostasisThe plasma fraction of stored erythrocytes augments pancreatic cancer metastasis in male versus female mice.A preclinical murine model of hepatic metastases.Modulation of the leptin receptor mediates tumor growth and migration of pancreatic cancer cells.Tumour suppression induced by the macrophage activating lipopeptide MALP-2 in an ultrasound guided pancreatic carcinoma mouse modelUse of multifunctional sigma-2 receptor ligand conjugates to trigger cancer-selective cell death signalingCharacterization of myeloid leukocytes and soluble mediators in pancreatic cancer: importance of myeloid-derived suppressor cells.Tissue factor expressed by circulating cancer cell-derived microparticles drastically increases the incidence of deep vein thrombosis in miceTuftsin augments antitumor efficacy of liposomized etoposide against fibrosarcoma in Swiss albino mice.Attenuated Toxoplasma gondii Stimulates Immunity to Pancreatic Cancer by Manipulation of Myeloid Cell Populations.Dendritic cell-based vaccination combined with gemcitabine increases survival in a murine pancreatic carcinoma model.Characterization of novel carcinoma cell lines for the analysis of therapeutical strategies fighting pancreatic cancerAnimal Models of Gastrointestinal and Liver Diseases. The difficulty of animal modeling of pancreatic cancer for preclinical evaluation of therapeutics.
P2860
Q24622837-3FCCFD89-8531-44B6-965A-04290717ECC7Q28535288-9851E332-AB83-4B9B-B29E-F933C9E32943Q28547152-2208E8C9-C72F-49C0-8402-8BB870556A77Q30541201-553C6098-1F07-4EEF-82F1-D5B18FAEAC10Q33470026-401CC801-18B2-44DA-AAEC-1597C2F2293DQ33578477-D80DBB0F-ED63-4179-A3B5-A6CC64650432Q33591328-D7F8207E-BE8C-4E11-98C5-B9EBECCE91FCQ33672565-58B033D7-06BF-41F7-9ECC-4E5CA19E5B5CQ33703133-A8B84CE0-99AC-4A8C-8E10-017BF149201DQ33723063-314D1D4E-74A3-431B-ABF7-482163DC8CD7Q33751134-39E05E91-7727-454C-8227-A981C4B80FFAQ33806343-DE034080-6F94-4859-8260-67B65BF17F4AQ33817475-AE51F76F-335B-4C2A-9C9A-16BFC523524BQ33829152-7873D51E-A185-48F8-9017-4EA8D49B3CA8Q33894658-02BCC671-7FBA-426D-A033-77B34E9D2023Q33948383-4237E9DB-4472-4038-BC32-B71C31D770F2Q34018256-B9CE0B88-E582-468E-AA44-CF6844230071Q34087816-2A4D04F8-03C7-4114-88A9-35E12D61BA64Q34104012-62937771-C657-4B7A-83AE-5360510BE65FQ34158118-9DB2508E-23AD-4156-9090-148CB955F8EFQ34486464-77017488-F0C5-4BBC-BB9C-344C157ABF50Q34619029-28F50B06-9614-4750-AC64-4214F5871B06Q34644359-3C3C3F72-50B5-4948-966C-AE106AE17A87Q34669771-EBCA38E3-DC45-4B5D-A2F9-E06660F0CA31Q34898405-F9C0374A-E86F-4614-87E1-329F7AC17EB4Q35010079-0215CD55-E528-491A-828C-1DC88B5C5B6DQ35021013-2411B6D7-6D3A-49CD-AA01-AEFE6C923F98Q35023580-71467573-4AF0-4CFB-8AE6-A933EBF403FFQ35097390-14988531-EC9C-45AA-974A-59E77FA05A78Q35229297-E8FAA4E4-5ECD-42B3-9933-6545912689ECQ35547200-2CB77297-D99A-4B74-BEE3-BAB1BDA1EA51Q35596295-339FA789-F1BF-48FE-A70E-A3BB98B818F3Q35652832-9961FB8B-6A92-417F-A330-67D2DCBCB58BQ35799021-19EF0A6A-DCE0-43FD-A645-AD9188BDA2A7Q35832620-80A486B8-1822-4289-8919-F6DA19DA4CB7Q35868689-FC35AE44-2EA1-4066-9A9C-054BAF65D7B1Q35920573-1DAD5C4F-7302-4E98-892B-A5EA6605DC88Q35954142-221E8867-0F61-4ACF-9479-6980F3861E7FQ36001882-F9A7FCB3-7A49-473E-93BE-018F419D0930Q36017810-3A236CD5-C5F5-42CA-B2BD-DD6D272AA600
P2860
Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Induction and chemotherapeutic ...... the pancreas in C57BL/6 mice.
@en
Induction and chemotherapeutic ...... the pancreas in C57BL/6 mice.
@nl
type
label
Induction and chemotherapeutic ...... the pancreas in C57BL/6 mice.
@en
Induction and chemotherapeutic ...... the pancreas in C57BL/6 mice.
@nl
prefLabel
Induction and chemotherapeutic ...... the pancreas in C57BL/6 mice.
@en
Induction and chemotherapeutic ...... the pancreas in C57BL/6 mice.
@nl
P2093
P921
P1433
P1476
Induction and chemotherapeutic ...... f the pancreas in C57BL/6 mice
@en
P2093
Corbett TH
Griswold DP Jr
Leopold WR
Peckham JC
Roberts BJ
Schabel FM Jr
Wilkoff LJ
P304
P407
P577
1984-02-01T00:00:00Z